124 related articles for article (PubMed ID: 7358991)
1. Susceptibility of adherent versus suspension target cells derived from adherent tissue culture lines to cell-mediated cytotoxicity in rapid 51Cr-release assays.
Dorfman NA; Civin CI; Wunderlich JR
J Immunol Methods; 1980; 32(2):127-39. PubMed ID: 7358991
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated cytotoxicity of sensitized spleen cells against target liver cells--in vivo and in vitro study with a mouse model of experimental autoimmune hepatitis.
Mori T; Mori Y; Yoshida H; Ueda S; Ogawa M; Iesato K; Wakashin Y; Wakashin M; Okuda K
Hepatology; 1985; 5(5):770-7. PubMed ID: 4029889
[TBL] [Abstract][Full Text] [Related]
3. In vitro induction of cell-mediated immunity to murine leukemia cells. II. cytotoxic activity in vitro and tumor-neutralizing capacity in vivo of anti-leukemia cytotoxic lymphocytes generated in macrocultures.
Kedar E; Schwartzbach M; Raanan Z; Hefetz S
J Immunol Methods; 1977; 16(1):39-58. PubMed ID: 68086
[TBL] [Abstract][Full Text] [Related]
4. An isotope-release assay and terminal-labeling assay for measuring cell-mediated allograft and tumor immunity to small numbers of adherent target cells.
Tamerius JD; Garrigues HJ; Hellström I; Hellström KE
J Immunol Methods; 1978; 22(1-2):1-22. PubMed ID: 78950
[TBL] [Abstract][Full Text] [Related]
5. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
Kedar E; Bonavida B
J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
[TBL] [Abstract][Full Text] [Related]
6. Separation of effector cells mediating antibody-dependent cellular cytotoxicity (ADC) to erythrocyte targets from those mediating ADC to tumor targets.
Pollack SB; Nelson K; Grausz JD
J Immunol; 1976 Apr; 116(4):944-6. PubMed ID: 815438
[TBL] [Abstract][Full Text] [Related]
7. Role of adherent spleen cells in the induction of cytotoxic activity by Toxoplasma lysate antigen.
Miyahara K; Tose S; Sakurai H; Igarashi I; Saito A; Hirose T; Suzuki N
J Vet Med Sci; 1992 Aug; 54(4):629-35. PubMed ID: 1391171
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay.
Greenberg AH; Shen L; Medley G
Immunology; 1975 Oct; 29(4):719-29. PubMed ID: 810417
[TBL] [Abstract][Full Text] [Related]
9. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.
Herberman RB; Nunn ME; Lavrin DH
Int J Cancer; 1975 Aug; 16(2):216-29. PubMed ID: 50294
[TBL] [Abstract][Full Text] [Related]
10. In vitro induction of polyclonal killer T cells with 2-mercaptoethanol and the essential role of macrophages in this process.
Igarashi T; Okada M; Kishimoto T; Yamamura Y
J Immunol; 1977 May; 118(5):1697-703. PubMed ID: 67145
[TBL] [Abstract][Full Text] [Related]
11. Induction of increased graft-versus-host disease by mouse spleen cells sensitized in vitro to allogeneic tumor.
Einstein AB; Cheever MA; Fefer A
Transplantation; 1976 Dec; 22(6):589-94. PubMed ID: 12600
[TBL] [Abstract][Full Text] [Related]
12. Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells.
Gooding LR
J Immunol; 1977 Mar; 118(3):920-7. PubMed ID: 191529
[TBL] [Abstract][Full Text] [Related]
13. Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.
Orsini F; Pavelic Z; Mihich E
Cancer Res; 1977 Jun; 37(6):1719-26. PubMed ID: 66985
[TBL] [Abstract][Full Text] [Related]
14. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
15. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-mediated natural cytotoxicity of dimethyl sulfoxide-treated Friend erythroleukemia cells.
Hsu KH; Friedman H
J Natl Cancer Inst; 1985 Jul; 75(1):105-10. PubMed ID: 3859684
[TBL] [Abstract][Full Text] [Related]
17. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
18. A long-term 51chromium assay for in vitro cell-mediated tumor immunity. Correlation with simultaneously performed microplate assays.
Steele G; Sjögren HO; Lannerstad O; Stadenberg I
Int J Cancer; 1975 Oct; 16(4):682-93. PubMed ID: 1176212
[TBL] [Abstract][Full Text] [Related]
19. Increased humoral and cellular immunity in mice inoculated with allogeneic tumor cells attached to microcarrier beads.
Yefenof E; Schwartz S; Katz-Gross A
Immunol Lett; 1983 Jan; 6(1):39-43. PubMed ID: 6840814
[TBL] [Abstract][Full Text] [Related]
20. In vitro generation of suppressor cell activity: suppression of in vitro induction if cell-mediated cytotoxicity.
Hodes RJ; Hathcock KS
J Immunol; 1976 Jan; 116(1):167-77. PubMed ID: 128570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
